This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
UK antibody developer F-star Therapeutics has become a private, independent biot...
The Senate on Thursday voted 53-45 to confirm trained surgeon and former daytime...
Drugmakers have leverage and are getting “a real negotiation” with the governmen...
The FDA on Thursday approved Amgen’s rare disease drug Uplizna in an autoimmune ...
When President Donald Trump signed the Right to Try Act into law in 2018, he vow...
Just a day after HHS and many of its agencies like FDA, CDC and NIH saw thousand...
On Wednesday, Providence Health Plan, which mainly operates in Oregon as part of...
The FDA is being consolidated into five “shared services offices,” according to ...
Roche on Thursday shared early positive results for its Alzheimer’s candidate tr...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
PIPEs have fallen out of favor. The private investment in public equity, or ...
The FDA once again rejected Aldeyra's potential dry eye disease treatment, known...
What was once a promising area of cancer immunotherapy has had another late-stag...
MoonLake Immunotherapeutics gets financing worth up to $500M: The company will g...
Editor’s note: This is an updated and corrected version of a story that ran on A...
Oncologist Justin Bekelman started Daymark Health to better support cancer patie...